Takayasu's arteritis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farnaz Khalighinejad, MD [2]

Pharmacologic medical therapy is recommended among patients with Takayasu’s arteritis to control inflammatory process and hypertension. Pharmacologic medical therapies for include corticosteroids, IL-6 receptor inhibitor, B-cell depletion agents, and cytotoxic drugs.

• Pharmacologic medical therapy is recommended among patients with Takayasu’s arteritis to control inflammatory process and hypertension.^[1][2]
• Pharmacologic medical therapies for include corticosteroids, IL-6 receptor inhibitor, B-cell depletion agents, and cytotoxic drugs.

• 1 Corticosteroids
  • Preferred regimen (1): prednisone 1 mg/kg PO qd (Consider osteoporosis prevention)
• 2 IL-6 receptor inhibitor
  • Preferred regimen (1): Tocilizumab
• 3 B-cell depletion
  • Preferred regimen (1): Rituximab
• 4 Cytotoxic agents
  • Preferred regimen (1): methotrexate
  • Preferred regimen (2): azathioprine
  • Preferred regimen (3): cyclophosphamide

Template:WH Template:WS